• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, February 9, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Expert in symptoms and pain receives Society of General Internal Medicine’s highest award

Bioengineer by Bioengineer
April 5, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Regenstrief Institute

INDIANAPOLIS – Kurt Kroenke, MD, a Regenstrief Institute investigator and the director of the institute's education and training programs, has been named the recipient of the Society of General Internal Medicine's Robert J. Glaser award, the organization's highest award.

"The very fabric of modern primary care in the United States and internationally has been woven by Kurt Kroenke's research contributions," wrote the colleagues who nominated him for this honor. "Very few generalist researchers have had such a tremendous impact."

Dr. Kroenke's career has focused on the management of symptoms by primary care physicians, initially examining unexplained medical symptoms. This focus soon expanded to include underlying mental disorders, including depression and anxiety, that affect patient experience with symptoms.

Faced with the difficulty of diagnosing these problems in primary care, he co-developed easy, valid and reliable measurement tools for depression and anxiety. These instruments, which have been translated into over 100 languages, are used today in daily practice in most internists' offices and are the annual screening tool implemented by major healthcare institutions throughout the U.S. and Europe.

Currently his research focuses on chronic pain, a commonly troublesome symptom in primary care. His work in this area, funded by the National Institutes of Health and the Department of Veterans Affairs, examines the impact of treating depression on pain, assesses stepped care to optimize pain care effectiveness, tests novel methods to reduce race and socio-economic disparities in pain care and evaluates telecare management of chronic musculoskeletal pain.

An internationally respected author of 350 peer-reviewed publications, Dr. Kroenke is also recognized with this award as a skilled clinician and as the educator and mentor of a whole generation of researchers and educators.

In addition to his Regenstrief Institute appointments, he is an Indiana University Center for Health Services and Outcomes investigator, and an IU School of Medicine professor of medicine and a core investigator with the Veterans Affairs Health Services Research and Development Center for Health Information and Communication at the Richard L. Roudebush VA Medical Center.

Dr. Kroenke, who joined the Regenstrief Institute and Indiana University in 1997, is a former president of the Society of General Internal Medicine. He will be presented with the Glaser award on April 13 at the organization's annual meeting in Denver.

###

Media Contact

Cindy Fox Aisen
[email protected]
317-843-2275
@regenstrief

Home Page

Share12Tweet7Share2ShareShareShare1

Related Posts

Intensive Short-Duration Exercise Outperforms Standard Care in Treating Panic Disorder

Intensive Short-Duration Exercise Outperforms Standard Care in Treating Panic Disorder

February 9, 2026

Exercise’s Impact on SASP Biomarkers in Seniors Unexplored

February 9, 2026

UK’s Rising Synthetic Opioid Crisis: Nitazene-Linked Deaths May Be Underreported by Up to 33%

February 9, 2026

Evaluating Digital Diabetes Screening’s B2C Potential in Switzerland

February 8, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Mapping Tertiary Lymphoid Structures for Kidney Cancer Biomarkers

    50 shares
    Share 20 Tweet 13
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Intensive Short-Duration Exercise Outperforms Standard Care in Treating Panic Disorder

Exercise’s Impact on SASP Biomarkers in Seniors Unexplored

UK’s Rising Synthetic Opioid Crisis: Nitazene-Linked Deaths May Be Underreported by Up to 33%

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 74 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.